Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options

被引：21

作者：

Di Lullo, Luca ^{[1
]}

Ronco, Claudio ^{[2
]}

Granata, Antonio ^{[3
,4
]}

Paoletti, Ernesto ^{[5
]}

Barbera, Vincenzo ^{[1
]}

Cozzolino, Mario ^{[6
]}

Ravera, Maura ^{[5
]}

Fusaro, Maria ^{[7
]}

Bellasi, Antonio ^{[8
]}

机构：

[1] L Parodi Delfino Hosp, Dept Nephrol & Dialysis, Colleferro, Italy

[2] S Bortolo Hosp, Int Renal Res Inst, Vicenza, Italy

[3] S Giovanni di Dio Hosp, Dept Nephrol & Dialysis, Agrigento, Italy

[4] S Bortolo Hosp, Int Renal Res Inst, Vicenza, Italy

[5] San Martino Hosp, Dept Nephrol & Dialysis, Genoa, Italy

[6] S Paolo Hosp, Dept Hlth Sci, Milan, Italy

[7] Univ Padua, Dept Med, Padua, Italy

[8] St Anna Hosp, ASTT Lariana, Dept Nephrol & Dialysis, Como, Italy

来源：

CARDIORENAL MEDICINE | 2019年 / 9卷 / 01期

关键词：

Hyperkalemia; Chronic kidney disease; Heart failure; Renin-angiotensin-aldosterone system inhibitors; Potassium binder; CHRONIC KIDNEY-DISEASE; SODIUM ZIRCONIUM CYCLOSILICATE; HEART-FAILURE; SERUM POTASSIUM; RENAL-DISEASE; DOUBLE-BLIND; PATIROMER; OUTCOMES; ALDOSTERONE; ASSOCIATION;

D O I：

10.1159/000493395

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Chronic hyperkalemia (HK) is a serious medical condition that often manifests in patients with chronic kidney disease (CKD) and heart failure (HF) leading to poor outcomes and necessitating careful management by cardionephrologists. CKD, HF, diabetes, and renin-angiotensin-aldosterone system inhibitors use is known to induce HK. Current therapeutic options are not optimal, as pointed out by a large number of CKD and HF patients with HK. The following review will focus on the main risk factors for developing HK and also aims to provide a guide for a correct diagnosis and present new approaches to therapy. (C) 2018 S. Karger AG, Basel

引用

页码：8 / 21

页数：14

共 62 条

[21] Association of Hypo- and Hyperkalemia with Disease Progression and Mortality in Males with Chronic Kidney Disease: The Role of Race [J].

Hayes, John ;

Kalantar-Zadeh, Kamyar ;

Lu, Jun L. ;

Turban, Sharon ;

Anderson, John E. ;

Kovesdy, Csaba P. .

NEPHRON CLINICAL PRACTICE, 2012, 120 (01) :C8-C16

[22] Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis [J].

Heerspink, Hiddo J. Lambers ;

Kropelin, Tobias F. ;

Hoekman, Jarno ;

de Zeeuw, Dick .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (08) :2055-2064

[23]

Hollander-Rodriguez JC, 2006, AM FAM PHYSICIAN, V73, P283

[24] Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients -: Losartan intervention for endpoint reduction in hypertension study [J].

Ibsen, H ;

Olsen, MH ;

Wachtell, K ;

Borch-Johnsen, K ;

Lindholm, LH ;

Mogensen, CE ;

Dahlöf, B ;

Devereux, RB ;

de Faire, U ;

Fyhrquist, F ;

Julius, S ;

Kjeldsen, SE ;

Lederballe-Pedersen, O ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wan, Y .

HYPERTENSION, 2005, 45 (02) :198-202

[25] Predictors of Hyperkalemia and Death in Patients With Cardiac and Renal Disease [J].

Jain, Nishank ;

Kotla, Suman ;

Little, Bertis B. ;

Weideman, Rick A. ;

Brilakis, Emmanouil S. ;

Reilly, Robert F. ;

Banerjee, Subhash .

AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (10) :1510-1513

[26] Changes in Serum Potassium Levels During Hospitalization in Patients With Worsening Heart Failure and Reduced Ejection Fraction (from the EVEREST Trial) [J].

Khan, Sadiya S. ;

Campia, Umberto ;

Chioncel, Ovidiu ;

Zannad, Faiez ;

Rossignol, Patrick ;

Maggioni, Aldo P. ;

Swedberg, Karl ;

Konstam, Marvin A. ;

Senni, Michele ;

Nodari, Savina ;

Vaduganathan, Muthiah ;

Subacius, Haris ;

Butler, Javed ;

Gheorghiade, Mihai .

AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (06) :790-796

[27] Serum Potassium and Outcomes in CKD: Insights from the RRI-CKD Cohort Study [J].

Korgaonkar, Sonal ;

Tilea, Anca ;

Gillespie, Brenda W. ;

Kiser, Margaret ;

Eisele, George ;

Finkelstein, Fredric ;

Kotanko, Peter ;

Pitt, Bertram ;

Saran, Rajiv .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (05) :762-769

[28] Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia The HARMONIZE Randomized Clinical Trial [J].

Kosiborod, Mikhail ;

Rasmussen, Henrik S. ;

Lavin, Philip ;

Qunibi, Wajeh Y. ;

Spinowitz, Bruce ;

Packham, David ;

Roger, Simon D. ;

Yang, Alex ;

Lerma, Edgar ;

Singh, Bhupinder .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (21) :2223-2233

[29] Management of hyperkalaemia in chronic kidney disease [J].

Kovesdy, Csaba P. .

NATURE REVIEWS NEPHROLOGY, 2014, 10 (11) :653-662

[30] Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD [J].

Lepage, Laurence ;

Dufour, Anne-Claude ;

Doiron, Jessica ;

Handfield, Katia ;

Desforges, Katherine ;

Bell, Robert ;

Vallee, Michel ;

Savoie, Michel ;

Perreault, Sylvie ;

Laurin, Louis-Philippe ;

Pichette, Vincent ;

Lafrance, Jean-Philippe .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (12) :2136-2142

← 1 2 3 4 5 6 7 →